Details of the Drug | DrugMAP

General Information of Drug (ID: DMXOYIH)

Drug Name

GRN-1201

Indication

Disease Entry	ICD 11	Status	REF
Non-small-cell lung cancer	2C25.Y	Phase 2	[1]
Melanoma	2C30	Phase 1	[2]
Merkel cell carcinoma	2C34	Phase 1	[2]
------------------------------------------------------------------------------------

Cross-matching ID

TTD ID: D0A3CH

Repurposed Drugs (RPD)

Click to Jump to the Detailed RPD Information of This Drug

References

1	ClinicalTrials.gov (NCT03417882) GRN-1201 With Pembrolizumab in Subjects With Metastatic PD-L1+ NSCLC. U.S. National Institutes of Health.
2	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)